Search research articles
Contact Us
Filters
Showing results (141-150 of 177) with videos related to
Page
of 18
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 19, 2004
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates
Lance A Smith, Michael J Jackson, Ghassan Al-Barghouthy, et al.
Phytotherapy Research : PTR
|
January 26, 2018
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease
Ria Fisher, Louise Lincoln, Michael J Jackson, et al.
Neurochemical Research
|
July 24, 2012
Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase
Javier Iglesias-González, Sofía Sánchez-Iglesias, Estefanía Méndez-Álvarez, et al.
Journal of Neurochemistry
|
December 1, 2004
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms
Mei Gu, M M Iravani, M Irvani, et al.
Experimental Neurology
|
June 24, 2008
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response
Mahmoud M Iravani, Mona Sadeghian, Clement C M Leung, et al.
Proteomics
|
September 21, 2004
Induction of Mycobacterium avium proteins upon infection of human macrophages
Lara Brunori, Federico Giannoni, Luca Bini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 3, 2016
Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets
Louise Lincoln, Ria Fisher, Michael J Jackson, et al.
Experimental Neurology
|
April 15, 2004
Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease
Peter-Andreas Löschmann, Carmen De Groote, Lance Smith, et al.
Chemistry & Biodiversity
|
December 29, 2006
Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins
Angelo Carotti, Cosimo Altomare, Marco Catto, et al.
Free Radical Biology & Medicine
|
December 19, 2002
Uptake and metabolism of epicatechin and its access to the brain after oral ingestion
Manal M Abd El Mohsen, Gunter Kuhnle, Andreas R Rechner, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 177) with videos related to
Sort By:
Page
of 18
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 19, 2004
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates
Lance A Smith, Michael J Jackson, Ghassan Al-Barghouthy, et al.
Phytotherapy Research : PTR
|
January 26, 2018
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease
Ria Fisher, Louise Lincoln, Michael J Jackson, et al.
Neurochemical Research
|
July 24, 2012
Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase
Javier Iglesias-González, Sofía Sánchez-Iglesias, Estefanía Méndez-Álvarez, et al.
Journal of Neurochemistry
|
December 1, 2004
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms
Mei Gu, M M Iravani, M Irvani, et al.
Experimental Neurology
|
June 24, 2008
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response
Mahmoud M Iravani, Mona Sadeghian, Clement C M Leung, et al.
Proteomics
|
September 21, 2004
Induction of Mycobacterium avium proteins upon infection of human macrophages
Lara Brunori, Federico Giannoni, Luca Bini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 3, 2016
Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets
Louise Lincoln, Ria Fisher, Michael J Jackson, et al.
Experimental Neurology
|
April 15, 2004
Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease
Peter-Andreas Löschmann, Carmen De Groote, Lance Smith, et al.
Chemistry & Biodiversity
|
December 29, 2006
Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins
Angelo Carotti, Cosimo Altomare, Marco Catto, et al.
Free Radical Biology & Medicine
|
December 19, 2002
Uptake and metabolism of epicatechin and its access to the brain after oral ingestion
Manal M Abd El Mohsen, Gunter Kuhnle, Andreas R Rechner, et al.
Page
of 18